CR8010A - Regimenes de contraceptivos transdermicos extendidos - Google Patents

Regimenes de contraceptivos transdermicos extendidos

Info

Publication number
CR8010A
CR8010A CR8010A CR8010A CR8010A CR 8010 A CR8010 A CR 8010A CR 8010 A CR8010 A CR 8010A CR 8010 A CR8010 A CR 8010A CR 8010 A CR8010 A CR 8010A
Authority
CR
Costa Rica
Prior art keywords
progestagen
extended transdermal
transdermal contraceptive
regimes
cycle
Prior art date
Application number
CR8010A
Other languages
English (en)
Inventor
Joseph Friedman Andrew
D La Guardia Katherine
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR8010A publication Critical patent/CR8010A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describe un metodo de contracepcion que comprende el paso de administrar a una mujer que menstrua un ciclo de terapia contraceptiva, dicho ciclo de terapia incluyendo, por cuando menos 42 dias sucesivos, la administracion de una combinacion de un estrogeno y un progestageno en una dosificacion diaria contraceptivamente efectiva, en donde dicho progestageno es un progestageno inhibidor de sulfatasa potente.
CR8010A 2003-03-11 2005-09-28 Regimenes de contraceptivos transdermicos extendidos CR8010A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/385,597 US20030219471A1 (en) 2002-03-11 2003-03-11 Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens

Publications (1)

Publication Number Publication Date
CR8010A true CR8010A (es) 2009-01-16

Family

ID=32987305

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8010A CR8010A (es) 2003-03-11 2005-09-28 Regimenes de contraceptivos transdermicos extendidos

Country Status (12)

Country Link
US (1) US20030219471A1 (es)
EP (1) EP1613293A1 (es)
KR (1) KR20070006543A (es)
CN (1) CN1771024A (es)
AU (1) AU2003252139A1 (es)
BR (1) BR0318192A (es)
CA (1) CA2517778A1 (es)
CR (1) CR8010A (es)
EC (1) ECSP056009A (es)
MX (1) MXPA05009656A (es)
RU (1) RU2005128284A (es)
WO (1) WO2004080442A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US7320969B2 (en) 2001-12-05 2008-01-22 Duramed Pharmaceuticals, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7772219B2 (en) 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US7816546B2 (en) * 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
RU2403046C2 (ru) 2003-07-16 2010-11-10 Тева Вимен'С Хелс, Инк. Способы гормонального лечения с применением контрацептивных режимов с непрерывным введением эстрогена
TW200626161A (en) * 2004-10-07 2006-08-01 Duramed Pharmaceuticals Inc Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
ES2558030T3 (es) * 2006-03-02 2016-02-01 Warner Chilcott Company, Llc Método anticonceptivo oral multifásico de ciclo prolongado

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545397A (en) * 1969-03-17 1970-12-08 Dowty Technical Dev Ltd Air-cushion vehicles and like craft
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US5188835A (en) * 1986-06-16 1993-02-23 Kabi Pharmacia Ab Intravaginal devices
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4906463A (en) * 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US5006342A (en) * 1986-12-22 1991-04-09 Cygnus Corporation Resilient transdermal drug delivery device
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
JP3534775B2 (ja) * 1995-06-07 2004-06-07 オーソ―マクニール ファーマシューティカル，インコーポレイテッド １７−デアセチルノルゲスチマートを単独でまたはエストロゲンと組み合わせて投与するための経皮パッチおよび方法
JP2005519963A (ja) * 2002-03-11 2005-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 長期サイクルのエストロゲンおよびスルファターゼ阻害プロゲストゲン避妊レジメン

Also Published As

Publication number Publication date
AU2003252139A1 (en) 2004-09-30
MXPA05009656A (es) 2006-03-08
RU2005128284A (ru) 2006-02-10
BR0318192A (pt) 2006-03-21
EP1613293A1 (en) 2006-01-11
KR20070006543A (ko) 2007-01-11
CN1771024A (zh) 2006-05-10
ECSP056009A (es) 2006-07-28
WO2004080442A1 (en) 2004-09-23
US20030219471A1 (en) 2003-11-27
CA2517778A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
CR8010A (es) Regimenes de contraceptivos transdermicos extendidos
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
HRP20070188B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
BRPI0512991A (pt) uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto
TR200200406T2 (tr) Kadınlara oral olmayan yollarla androjenik steroidlerin uygulanması
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
AR056453A1 (es) Composiciones con estrogeno y metodos terapeuticos para su uso
JP2013514984A5 (es)
BRPI0412493A (pt) métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio
RU2011146058A (ru) Способ контрацепции, используемый по мере необходимости
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
JP2005516913A5 (es)
HUP0301791A2 (hu) Eljárás klimaktériummal összefüggő rendellenességek kezelésére nőkben a menopauza alatt vagy után
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
CO5690602A2 (es) Regimenes anticonceptivos trifasicos extendidos
KR900005974A (ko) 남성의 성기능 장애 치료제
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
ATE395047T1 (de) Feste perorale arzneiform zur kontrazeption, die dienogest und ethinylestradiol enthält
HUP0101005A2 (hu) Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére
AR049195A1 (es) Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
AR039547A1 (es) Terapia de reemplazo hormonal
NO20072687L (no) Farmasoytisk prevensjonspreparat

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)